Deals
XOMA Corp Raises $20M at 12% Discount From Hercules Technology Growth Capital
|
XOMA Corporation (NASDAQ GM:XOMA) announced that it has raised $20,000,000 in a Non-Convertible Debentures transaction.
Deals
Amarin Raises $52M for Lipid Treatment Enterprise
|
Lipid therapy specialist Amarin Corp. (NASDAQ GM: AMRN) has raised $52.8 million in a convertible preferred stock offering. Amarin makes VASCEPA, which the company styles the first FDA-approved Omega-3 product. VASCEPA is designed to lower triglyceride levels without increasing levels of LDL, the "bad" cholesterol. Amarin stock was up 6.59% when he deal closed on March 6.
Deals
$50M Preferred Offering from Merge Healthcare
|
Guggenheim Advisors led a $50 million investment round in Merge Healthcare (NASDAQ: MRGE). The imaging company has also announced the acquisition of DR Systems.
Deals
Coronado Biosciences Raises $10M, Forms Subsidiary
|
Coronado Biosciences (NASDAQ: CNDO) has raised $10 million in a three-year non-convertible promissory note offering featuring an 8% coupon. National Securities Corp. was the agent.
